Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 35 | 2018 | 3757 | 2.980 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1275 | 1.750 |
Why?
|
Muscle, Skeletal | 17 | 2024 | 4901 | 1.640 |
Why?
|
Pseudomonas Infections | 8 | 2024 | 621 | 1.340 |
Why?
|
Burns | 10 | 2013 | 1849 | 1.310 |
Why?
|
Brain Neoplasms | 20 | 2016 | 8981 | 1.040 |
Why?
|
Acetophenones | 3 | 2024 | 52 | 1.030 |
Why?
|
Robotics | 5 | 2019 | 819 | 1.000 |
Why?
|
Quorum Sensing | 6 | 2024 | 137 | 0.850 |
Why?
|
Adenosine Triphosphate | 8 | 2024 | 1986 | 0.830 |
Why?
|
Magnetic Resonance Imaging | 24 | 2023 | 36270 | 0.820 |
Why?
|
Mitochondria | 11 | 2024 | 3583 | 0.810 |
Why?
|
Drosophila melanogaster | 4 | 2015 | 1708 | 0.680 |
Why?
|
Ion Channels | 3 | 2015 | 1043 | 0.620 |
Why?
|
Mitochondrial Proteins | 3 | 2015 | 976 | 0.570 |
Why?
|
Volatile Organic Compounds | 1 | 2018 | 84 | 0.570 |
Why?
|
Hand Strength | 2 | 2019 | 452 | 0.560 |
Why?
|
Insulin Resistance | 4 | 2015 | 3941 | 0.560 |
Why?
|
Lipid Metabolism | 9 | 2010 | 1895 | 0.520 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 509 | 0.500 |
Why?
|
Citric Acid Cycle | 2 | 2013 | 230 | 0.500 |
Why?
|
Contrast Media | 4 | 2018 | 5297 | 0.490 |
Why?
|
Neuronal Plasticity | 3 | 2013 | 1429 | 0.480 |
Why?
|
Stroke | 5 | 2023 | 9695 | 0.460 |
Why?
|
Mitochondria, Muscle | 2 | 2024 | 172 | 0.450 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1475 | 0.430 |
Why?
|
Thoracic Injuries | 1 | 2015 | 280 | 0.430 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2056 | 0.430 |
Why?
|
Drosophila Proteins | 2 | 2014 | 1698 | 0.420 |
Why?
|
Cachexia | 2 | 2013 | 197 | 0.420 |
Why?
|
Oligopeptides | 3 | 2024 | 1184 | 0.410 |
Why?
|
Glutathione Transferase | 1 | 2014 | 564 | 0.400 |
Why?
|
Apoptosis | 5 | 2016 | 9466 | 0.360 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2475 | 0.360 |
Why?
|
Gene Expression Profiling | 8 | 2012 | 9403 | 0.360 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 340 | 0.340 |
Why?
|
Magnetite Nanoparticles | 1 | 2010 | 315 | 0.320 |
Why?
|
Dextrans | 1 | 2010 | 573 | 0.310 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3774 | 0.310 |
Why?
|
Wound Infection | 1 | 2010 | 243 | 0.310 |
Why?
|
Aspartic Acid | 5 | 2004 | 576 | 0.300 |
Why?
|
Image Enhancement | 1 | 2018 | 2880 | 0.300 |
Why?
|
Glycine | 2 | 2010 | 662 | 0.300 |
Why?
|
Oxidative Stress | 2 | 2016 | 3102 | 0.290 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1442 | 0.290 |
Why?
|
Antioxidants | 2 | 2019 | 1665 | 0.270 |
Why?
|
Lipids | 4 | 2014 | 3326 | 0.240 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2015 | 162 | 0.240 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2008 | 1491 | 0.230 |
Why?
|
Choline | 8 | 2004 | 513 | 0.230 |
Why?
|
Energy Metabolism | 2 | 2024 | 2867 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 8946 | 0.220 |
Why?
|
Genomics | 2 | 2010 | 5788 | 0.210 |
Why?
|
Protons | 5 | 2008 | 1112 | 0.210 |
Why?
|
Macrophages | 2 | 2024 | 5732 | 0.210 |
Why?
|
Mice | 18 | 2024 | 81066 | 0.210 |
Why?
|
Paresis | 1 | 2023 | 176 | 0.200 |
Why?
|
Brain | 11 | 2013 | 26952 | 0.200 |
Why?
|
Animals | 23 | 2024 | 167718 | 0.200 |
Why?
|
Asphyxia Neonatorum | 1 | 2002 | 111 | 0.200 |
Why?
|
Hindlimb | 4 | 2008 | 508 | 0.190 |
Why?
|
Trans-Activators | 2 | 2008 | 2859 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 823 | 0.190 |
Why?
|
Hand | 3 | 2019 | 902 | 0.180 |
Why?
|
Biopsy | 6 | 2016 | 6757 | 0.180 |
Why?
|
Artificial Intelligence | 2 | 2012 | 2548 | 0.180 |
Why?
|
Down-Regulation | 1 | 2008 | 2901 | 0.180 |
Why?
|
Blood Volume | 1 | 2002 | 548 | 0.180 |
Why?
|
Lactic Acid | 3 | 2004 | 1133 | 0.180 |
Why?
|
Central Nervous System Neoplasms | 2 | 2007 | 916 | 0.170 |
Why?
|
Glioblastoma | 3 | 2012 | 3480 | 0.170 |
Why?
|
Insulin | 2 | 2014 | 6578 | 0.170 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2725 | 0.170 |
Why?
|
Oxidative Phosphorylation | 3 | 2024 | 495 | 0.170 |
Why?
|
Magnetic Resonance Angiography | 2 | 2004 | 1431 | 0.160 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4886 | 0.160 |
Why?
|
Motor Activity | 1 | 2009 | 2685 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8503 | 0.160 |
Why?
|
Mice, Inbred Strains | 3 | 2010 | 1758 | 0.150 |
Why?
|
Body Surface Area | 2 | 2008 | 197 | 0.150 |
Why?
|
Brain Chemistry | 4 | 2004 | 959 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2010 | 553 | 0.140 |
Why?
|
Speech Perception | 1 | 2002 | 505 | 0.140 |
Why?
|
Spin Labels | 2 | 2008 | 336 | 0.140 |
Why?
|
Aging | 1 | 2015 | 8654 | 0.140 |
Why?
|
Carbohydrate Metabolism | 2 | 2009 | 262 | 0.140 |
Why?
|
Humans | 42 | 2024 | 757566 | 0.140 |
Why?
|
Arousal | 1 | 2002 | 1157 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2024 | 2127 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2008 | 11082 | 0.130 |
Why?
|
Algorithms | 4 | 2009 | 13952 | 0.130 |
Why?
|
Metabolome | 2 | 2014 | 982 | 0.130 |
Why?
|
Child | 17 | 2016 | 79782 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 293 | 0.120 |
Why?
|
Glioma | 3 | 2012 | 3417 | 0.120 |
Why?
|
Male | 30 | 2024 | 358180 | 0.120 |
Why?
|
Moyamoya Disease | 1 | 1997 | 256 | 0.110 |
Why?
|
Cerebellum | 2 | 2013 | 1497 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11890 | 0.110 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 92 | 0.110 |
Why?
|
Amino Acids | 2 | 2010 | 1712 | 0.110 |
Why?
|
Inositol | 2 | 2010 | 215 | 0.110 |
Why?
|
Motor Cortex | 2 | 2013 | 997 | 0.110 |
Why?
|
Psychomotor Performance | 1 | 2002 | 1878 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2013 | 2223 | 0.110 |
Why?
|
Aconitate Hydratase | 1 | 2013 | 16 | 0.110 |
Why?
|
Transcription Factors | 6 | 2024 | 12092 | 0.110 |
Why?
|
Neoplasms | 2 | 2013 | 21986 | 0.110 |
Why?
|
Physical Conditioning, Animal | 1 | 2016 | 364 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 61 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2009 | 12761 | 0.100 |
Why?
|
Mutation | 2 | 2014 | 29929 | 0.100 |
Why?
|
Child, Preschool | 11 | 2009 | 42045 | 0.100 |
Why?
|
Infant | 10 | 2009 | 36045 | 0.100 |
Why?
|
Attention | 1 | 2002 | 2387 | 0.100 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 695 | 0.090 |
Why?
|
Signal Transduction | 2 | 2014 | 23335 | 0.090 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2019 | 540 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2010 | 6230 | 0.090 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3824 | 0.090 |
Why?
|
Reference Values | 2 | 2012 | 4918 | 0.090 |
Why?
|
Microarray Analysis | 1 | 2013 | 745 | 0.090 |
Why?
|
Adolescent | 12 | 2010 | 87819 | 0.090 |
Why?
|
Receptors, Glucagon | 1 | 2010 | 90 | 0.090 |
Why?
|
Databases, Factual | 1 | 2006 | 7927 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18114 | 0.090 |
Why?
|
Glutarates | 1 | 2012 | 243 | 0.090 |
Why?
|
Nerve Net | 1 | 2002 | 2264 | 0.090 |
Why?
|
PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2012 | 273 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1293 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 1993 | 519 | 0.080 |
Why?
|
Random Allocation | 2 | 2010 | 2388 | 0.080 |
Why?
|
PPAR alpha | 1 | 2009 | 175 | 0.080 |
Why?
|
Phosphorus Isotopes | 1 | 2008 | 124 | 0.080 |
Why?
|
Fatty Acids | 2 | 2006 | 1803 | 0.080 |
Why?
|
Regression Analysis | 2 | 2008 | 6337 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 240 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 21990 | 0.070 |
Why?
|
Muscular Atrophy | 1 | 2010 | 327 | 0.070 |
Why?
|
Astrocytoma | 1 | 2012 | 775 | 0.070 |
Why?
|
Chronic Disease | 2 | 2013 | 9263 | 0.070 |
Why?
|
Ischemia | 1 | 2016 | 1863 | 0.070 |
Why?
|
Prognosis | 4 | 2011 | 29488 | 0.070 |
Why?
|
Models, Biological | 3 | 2008 | 9459 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1054 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2013 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7399 | 0.070 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 392 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2010 | 557 | 0.070 |
Why?
|
Logistic Models | 3 | 2011 | 13221 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1044 | 0.070 |
Why?
|
Artificial Limbs | 1 | 2008 | 121 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1511 | 0.070 |
Why?
|
Blotting, Western | 1 | 2013 | 5031 | 0.070 |
Why?
|
Cerebral Cortex | 1 | 2002 | 5756 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2008 | 20037 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 928 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 795 | 0.060 |
Why?
|
Phantoms, Imaging | 2 | 2012 | 2509 | 0.060 |
Why?
|
Electron Transport | 1 | 2005 | 205 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 609 | 0.060 |
Why?
|
Metabolomics | 1 | 2013 | 1629 | 0.060 |
Why?
|
Glycolysis | 1 | 2008 | 826 | 0.060 |
Why?
|
Gluconeogenesis | 1 | 2005 | 185 | 0.060 |
Why?
|
Radiography | 2 | 2013 | 6956 | 0.060 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2003 | 46 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2009 | 7588 | 0.050 |
Why?
|
Meningioma | 1 | 2012 | 1217 | 0.050 |
Why?
|
Cold Temperature | 1 | 2006 | 780 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2969 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1419 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14637 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13263 | 0.050 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2001 | 38 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 771 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2006 | 620 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2008 | 2105 | 0.050 |
Why?
|
Models, Neurological | 1 | 2009 | 1757 | 0.050 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 623 | 0.040 |
Why?
|
Virulence Factors | 1 | 2024 | 511 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1896 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2007 | 2696 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2496 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 820 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2868 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 812 | 0.040 |
Why?
|
Age Factors | 2 | 2010 | 18326 | 0.040 |
Why?
|
Epilepsy | 2 | 2012 | 3270 | 0.040 |
Why?
|
Creatine | 2 | 2004 | 426 | 0.040 |
Why?
|
Female | 14 | 2012 | 389943 | 0.040 |
Why?
|
Xanthine Oxidase | 1 | 2019 | 69 | 0.040 |
Why?
|
Lactates | 2 | 2000 | 404 | 0.040 |
Why?
|
Adult | 10 | 2012 | 219725 | 0.040 |
Why?
|
NADP | 1 | 2019 | 222 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2019 | 261 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10075 | 0.040 |
Why?
|
Neural Pathways | 1 | 2009 | 3040 | 0.040 |
Why?
|
Wakefulness | 1 | 2005 | 1256 | 0.040 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2001 | 352 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2891 | 0.040 |
Why?
|
Virulence | 2 | 2014 | 1298 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6198 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1005 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5194 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2208 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4937 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6204 | 0.030 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.030 |
Why?
|
Disease Progression | 2 | 2004 | 13463 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2295 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2000 | 849 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6323 | 0.030 |
Why?
|
Young Adult | 3 | 2012 | 58755 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 22022 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2019 | 1150 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 12870 | 0.030 |
Why?
|
Gene Expression | 1 | 2006 | 7584 | 0.030 |
Why?
|
Drug Resistance, Multiple | 1 | 2014 | 253 | 0.030 |
Why?
|
Capillaries | 1 | 2016 | 744 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1065 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12397 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25924 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 869 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 856 | 0.020 |
Why?
|
Middle Aged | 4 | 2012 | 219192 | 0.020 |
Why?
|
Heart Arrest | 1 | 2001 | 1494 | 0.020 |
Why?
|
Extremities | 1 | 2016 | 865 | 0.020 |
Why?
|
Creatinine | 1 | 1996 | 1892 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 15207 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1477 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2003 | 26176 | 0.020 |
Why?
|
Virus Cultivation | 1 | 2007 | 88 | 0.020 |
Why?
|
Time Factors | 2 | 2006 | 39811 | 0.020 |
Why?
|
Hemodynamics | 1 | 1997 | 4156 | 0.020 |
Why?
|
Rheology | 1 | 2008 | 348 | 0.020 |
Why?
|
Brain Mapping | 1 | 2002 | 6571 | 0.020 |
Why?
|
Central Nervous System | 1 | 1993 | 1332 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8296 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 18936 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2002 | 9245 | 0.010 |
Why?
|
Hydrogen | 1 | 2003 | 171 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1993 | 2650 | 0.010 |
Why?
|
Quinolines | 1 | 2007 | 758 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2007 | 1131 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7336 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2007 | 64242 | 0.010 |
Why?
|
Phosphorylcholine | 1 | 2000 | 153 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1976 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 469 | 0.010 |
Why?
|
Gliosis | 1 | 2000 | 244 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2001 | 553 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5856 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 5781 | 0.010 |
Why?
|
Resuscitation | 1 | 2001 | 661 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2001 | 1828 | 0.010 |
Why?
|
Brain Stem | 1 | 2001 | 857 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 1604 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 1040 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 2901 | 0.010 |
Why?
|
Inflammation | 1 | 2006 | 10709 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15781 | 0.000 |
Why?
|
Aged | 1 | 2012 | 167890 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2003 | 79984 | 0.000 |
Why?
|